An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA(R)) in adults: safety, tolerability, and immunogenicity

By Linglof T.   van Hattum J.   Kaplan K.M.   Corrigan J.   Duval I.   Jensen E.   Kuter B.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3968-3971

Elsevier

Access to resources Recommend Favorite

Erratum to ''An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA ( R)) in adults: safety, tolerability, and immunogenicity'' - [Vaccine 19 (2001) 3968-3971]

By Linglof T.   Hattum J.v.   Kaplan K.M.   Corrigan J.   Duval I.   Jensen E.   Kuter B.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 281-281

Elsevier

Access to resources Recommend Favorite

A randomised comparison of two inactivated hepatitis A vaccines, Avaxim&unknown; and Vaqta&unknown;, given as a booster to subjects primed with Avaxim&unknown;

By Clarke P.   Kitchin N.   Souverbie F.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4429-4433

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

Inactivated hepatitis A vaccine: long-term antibody persistence

By Wiedermann G.   Kundi M.   Ambrosch F.   Safary A.   D'Hondt E.   Delem A.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 612-615

Elsevier

Access to resources Recommend Favorite